Skip to content
Popular Searches
  • # Cancer
  • # Alzheimer's
  • # FDA
  • # DNA
  • # COVID19
  • # CRISPR
  • linkedin
  • facebook
  • instagram
  • twitter
Home BiotechReality – Covering Industry, Business, and Academia

Explore the frontiers of Biotechnology, Pharma/Biopharma industry and Science with BiotechReality. We publish news, reports, views and articles.

  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
Trending

Trending

Research: Fighting cancer with its strength using modified T cells

10 February 2024

Engineers Converted Skin Cells to Neurons for Cell Therapy Purpose

16 March 2025

Can milk overcome diabetes? The first insulin-producing transgenic cow created

14 March 2024

A new way to boost the immune cells to fight against cancer cells

22 April 2024

A Neutralizing Antibody for Inhibitory Factors in Nerve Regeneration Promotes Improved Motor Function

21 December 2024

Spike mutations promote brain infection by SARS-CoV-2

25 August 2024

Gene variants of Neanderthal associated with greater pain sensitivity; University College London

4 November 2023

Opthea Released COAST Phase 3 Clinical Trial Results

24 March 2025

Harmful immune responses can be prevented by redesigning future mRNA-based therapeutics – Research

17 December 2023

Amgen Reports Strong Q1 2025 Results Driven by Robust Volume Growth and Key Product Performance

5 May 2025

Researchers found the impact on hormone levels in mice by gut microbiome

30 September 2024

SARS-CoV-2 which causes COVID-19 is widespread in wild animals

31 July 2024

inebilizumab

Amgen Released Phase 3 MINT Trial Data Evaluating the Efficacy and Safety of UPLIZNA® (inebilizumab-cdon)
Clinical Trials Healthcare & Pharmaceuticals News

Amgen Released Phase 3 MINT Trial Data Evaluating the Efficacy and Safety of UPLIZNA® (inebilizumab-cdon)

Editor's Desk 14 March 2025

The trial achieved its primary endpoint, as previously revealed at the 2024 American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting.

Areas Covered

  • Anti-obesity Drugs
  • Applications of Biotechnology
  • Artificial Intelligence
  • Astrobiology
  • Biochemistry
  • Bioengineering
  • Bioinformatics
  • Biostatistics
  • Biotechnology
  • Blog
  • Business
  • Cancer
  • Cell Biology
  • Clinical Investigation
  • Clinical Trials
  • Collection
  • Deep Learning
  • Diabetes
  • Diagnostic Tests
  • Disease Biology
  • Diseases
  • Drug Discovery
  • Drugs
  • Engineering
  • Epidemiology
  • Gene Therapy
  • General Biology
  • Genetics
  • Genomics
  • Healthcare & Pharmaceuticals
  • Immunology
  • Immunotherapy
  • Instrumentation
  • Laboratory Info
  • Life Sciences
  • Machine Learning
  • Medical Devices
  • Mental Health
  • Microbiology
  • Microscopy
  • Molecular Biology
  • Nanotechnology
  • Neuroscience
  • News
  • Pharmacology
  • Regenerative Medicine
  • Regulatory
  • Regulatory Approval
  • Research
  • Science
  • Science Communication
  • Staining
  • Technology
  • Therapies
  • Toxicology
  • Vaccines
  • Virology
  • Weight-loss Drugs
Market Analysis
Publish on BiotechReality

  • Amgen Hiring Senior Data Engineer in Hyderabad, India – May 2025
  • Novo Nordisk Hiring Senior Regulatory Affairs Specialist in Seoul, South Korea – May 2025
  • Pfizer Hiring an IT Senior Associate in Chennai, India – April, 2025
  • IQVIA Hiring Clinical Data Specialist in Cochin, India – April 2025
  • Amgen Hiring CRM Engineer (Veeva/Salesforce) in Hyderabad, India – April, 2025
SciRealityPress BiotechReality

A SciRealityPress Associate

Contents in the website is licensed under CC BY-NC 4.0

Disclaimer: The content on this website is not meant to provide medical or any other professional advice. Understand and use the information, double check if necessary. All trademarked names mentioned in the contents belongs to their respective owners. Stock exchange data providing by Stockdio

SciRealityPress © 2025
  • About
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Platform Status
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinuePrivacy policy